About Namrata Sen Chanda
Namrata is an accomplished financial journalist, with nearly a decade of experience. She specializes in interpreting news releases and framing investment strategies, and has worked with some of the leading companies in real estate, banking, insurance, mutual funds, financial research, fintech, and investment education.
After majoring in finance at college, she became a research analyst, tracking economic indicators and analyzing major global economic developments. She then went on to become a contributing author for the Market Realist, focusing on the technology sector.
Namrata has a keen interest in fundamental analysis and is passionate about educating investors about the stock market.
Recent Articles By Namrata Sen Chanda
3 "Buy Rated" Stocks to Buy for a Cold Winter
La Niña could bring a colder-than-normal winter across the North. With a chilly winter around the corner, companies with seasonal businesses are likely to see robust demand. Public Service Enterprise Group (PEG), Domino's Pizza (DPZ), and Columbia Sportswear (COLM) should significantly benefit if the winter is colder than normal.
4 Coronavirus Stocks to Buy for the Second Wave
With single day coronavirus cases crossing the 100,000 threshold in the US, the second wave of COVID-19 is intensifying. Johnson & Johnson (JNJ), Teladoc (TDOC), and Quidel (QDEL) have been responsive in ensuring health safety during the crisis. Meanwhile, Zoom (ZM) has made virtual connectivity simpler to stay functional. Shares of these companies could continue to soar even if the second wave takes a significant toll on the economy and the markets.
3 "Buy-Rated" Robinhood Stocks to Buy if the Market Plunges
The Robinhood 100 list is not only a good way to gauge where millennials are investing in, but to also find popular investment trends. Zoom (ZM), Berkshire Hathaway (BRK.B), and Shopify (SHOP) are on the popular list and also have strong fundamental strength. These companies could be great additions to hedge your portfolio against a possible market sell-off.
3 Dividend-Paying Stocks with INSIDER BUYING
The current uncertainty in the markets is leading investors to seek stocks that not only pay a regular dividend but also have the potential to deliver price gains. Insider buying is one of the best ways to gauge the capital appreciation prospects of a stock. Three such stocks that score on both are FedEx (FDX), Keurig Dr Pepper (KDP), and Dow (DOW).
3 'Buy the Dip' Tech Stocks for November
Looming concerns over a second wave of COVID-19 and election results have been erasing some of the market's solid gains since mid-March. However, the technology sector has the potential to quickly return to its bull run based on its ability to capitalize on the pandemic. Thus, this market dip is a good opportunity to buy some fundamentally sound tech stocks like Qualcomm (QCOM), ServiceNow (NOW), and Chegg (CHGG).
3 Stocks Set to Soar from the Second Wave of Covid-19
With daily coronavirus cases crossing 87,000 in the United States, the second wave is already making its presence felt. Companies like Johnson & Johnson (JNJ), Abbott (ABT), and Teladoc (TDOC) have been instrumental in delivering quality healthcare amid this health crisis. Their ability to capitalize on the pandemic should help their stocks soar with the increased intensity of the health crisis.
3 Breakthrough Tech Stocks to Buy for November
The second wave of coronavirus, fiscal stimulus negotiations, and the election are leading to increased stock market volatility in November. However, investors are expected to keep accumulating technology shares due to its resilience and strong returns. Among the tech players, breakthrough tech stocks like NVIDIA (NVDA), Adobe (ADBE), and ServiceNow (NOW) could be the best bets considering their enormous growth potential.
4 iPhone 12 Stocks That Could Jump with Apple's Earnings Report
Taiwan Semiconductor (TSM), Broadcom (AVGO), Qualcomm (QCOM), and NXP Semiconductors (NXPI) are the four companies poised to benefit from the iPhone upgrade cycle. With all eyes on Apple’s (AAPL) fourth quarter results, these four chip stocks could see a sharp uptick in prices.
4 Innovative Biotech Stocks That Could Dominate Healthcare in 2021
Aging population, lifestyle changes and pandemics have created a huge demand for patient-focused healthcare. Biotech stocks like Seagen (SGEN), Genmab A/S (GMAB), Amedisys (AMED), and Masimo (MASI) could dominate the industry based on their disruptive technology, unique offerings and tremendous growth potential.